drugset / Trial / NCT00617812

Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine

NCT00617812 ↗

Phase 4 Completed 160 enrolled Shantha Biotechnics Limited
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the safety and immunogenicity of an indigenously developed liquid pentavalent (diphtheria, tetanus, pertussis, hepatitis B and Hib) combination vaccine in healthy Indian infants as a part of the routine immunization in accordance with the EPI schedule.

Timeline

Start
2008-03
Primary completion
2009-04
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Shan 5 Vaccine — —